Alpha Tau Medical Ltd (NASDAQ:DRTS) — Market Cap & Net Worth
Market Cap & Net Worth: Alpha Tau Medical Ltd (DRTS)
Alpha Tau Medical Ltd (NASDAQ:DRTS) has a market capitalization of $614.75 Million ($614.75 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #11026 globally and #2875 in its home market, demonstrating a -10.95% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Alpha Tau Medical Ltd's stock price $11.79 by its total outstanding shares 85264146 (85.26 Million). See DRTS capex to operating cash flow ratio to understand how much of operating cash flow is reinvested back into capital assets.
Alpha Tau Medical Ltd Market Cap History: 2021 to 2026
Alpha Tau Medical Ltd's market capitalization history from 2021 to 2026. Data shows growth from $837.29 Million to $1.01 Billion (2.91% CAGR).
Index Memberships
Alpha Tau Medical Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.02% | #302 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #1127 of 3165 |
Weight: Alpha Tau Medical Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Alpha Tau Medical Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Alpha Tau Medical Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of DRTS by Market Capitalization
Companies near Alpha Tau Medical Ltd in the global market cap rankings as of August 3, 2026.
Key companies related to Alpha Tau Medical Ltd by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #220 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #424 globally with a market cap of $64.60 Billion USD.
- Argen-X (BR:ARGX): Ranked #543 globally with a market cap of $49.55 Billion USD ( €42.38 Billion EUR).
- UCB SA (BR:UCB): Ranked #563 globally with a market cap of $47.34 Billion USD ( €40.49 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #220 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $477.10 |
| #424 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $64.60 Billion | $762.63 |
| #543 | Argen-X | BR:ARGX | $49.55 Billion | €745.00 |
| #563 | UCB SA | BR:UCB | $47.34 Billion | €222.90 |
Alpha Tau Medical Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Alpha Tau Medical Ltd's market cap moved from $837.29 Million to $ 1.01 Billion, with a yearly change of 2.91%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.01 Billion | +138.18% |
| 2025 | $422.06 Million | +59.68% |
| 2024 | $264.32 Million | +2.99% |
| 2023 | $256.65 Million | -5.35% |
| 2022 | $271.14 Million | -67.62% |
| 2021 | $837.29 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Alpha Tau Medical Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $614.75 Million USD |
| MoneyControl | $614.75 Million USD |
| MarketWatch | $614.75 Million USD |
| marketcap.company | $614.75 Million USD |
| Reuters | $614.75 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Alpha Tau Medical Ltd
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical or pending cl… Read more